Chromatographic analysis and decomposition product characterization of compound SR16157 (NSC 732011)

Journal of Pharmaceutical and Biomedical Analysis

Volumn 45, Issue 4, 2007, Pages 572-582

  Wang, Jennie ^a   ChunYang, ^a   Wang, Euphemia ^a   Li, Shihong ^a   Zaveri, Nurulain ^a   Liu, Paul ^b  

^a SRI INTERNATIONAL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Forced decomposition; HPLC assay; Impurity characterization; NSC 732011; SR16157; Validation

Indexed keywords

21 (2 N,N DIETHYLAMINOETHYL)OXY 7ALPHA METHYL 19 NORPREGNA 1,3,5(10) TRIENE 3 O SULFAMATE; ENZYME INHIBITOR; ESTRONE SULFATASE INHIBITOR; SR 16137; SR 16157; SULFUR ACID AMIDE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; BREAST CANCER; DECOMPOSITION; DRUG MECHANISM; ENZYME ACTIVITY; ESTROGEN SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROXYLATION; OXIDATION; PRIORITY JOURNAL; REACTION ANALYSIS; VALIDATION PROCESS;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CONTAMINATION; DRUG EVALUATION, PRECLINICAL; DRUG STABILITY; ENZYME INHIBITORS; HUMANS; HYDROLYSIS; MOLECULAR STRUCTURE; NORPREGNATRIENES; OXIDATION-REDUCTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SULFATASES; TANDEM MASS SPECTROMETRY;

EID: 35548977076     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.08.015     Document Type: Article

References (22)

1. Pasqualini J.R., and Chetrite G.S. J. Steriod Biochem. Mol. Biol. 93 (2005) 221-236
2. Santen R.J., Leszczynski D., Tilson-Mallet N., Feil P.D., Wright C., Manni A., and Santner S.J. Ann. N.Y. Acad. Sci. 464 (1986) 126-137
3. Santner S.J., Feil P.D., and Santen R.J. J. Clin. Endocrinol. Metab. 59 (1984) 29-33
4. Chetrite G.S., Cortes-Prieto J., Philippe J.C., Wright F., and Pasqualini J.R. J. Steroid Biochem. Mol. Biol. 72 (2000) 23-27
5. Utsumi T., Yoshimura N., Takeuchi S., Maruta M., Maeda K., and Harada N. J. Steroid Biochem. Mol. Biol. 72 (2000) 141-145
6. Reed M.J., Purohit A., Woo L.W., Newman S.P., and Potter B.V. Endocr. Rev. 26 (2005) 171-202
7. Stanway S.J., Delavault P., Purohit A., Woo L.W., Thurieau C., Potter B.V., and Reed M.J. Oncologist 12 (2007) 370-374
8. Rausch L., Robb A., Catz P., LeValley S.E., Harrison T., Steinmetz K.L., Green C.E., Tomaszewski J., Schweikart K., Zaveri N., and Mirsalis J.C. Proc. Am. Assoc. Cancer Res. 47 (2006) (Abstract # 3100)
9. L.M. Rasmussen, N.T. Zaveri, J. Stenvang, R.H. Peters, A.E. Lykkesfeldt, Breast Cancer Res. Treatment. (2007) (Epub ahead of print).
10. Görög S. Anal. Sci. 20 (2004) 767-782
11. Görög S. Fresenius Z. Anal. Chem. 309 (1981) 97-104
12. Nygaard L., Kilde H.D., Andersen S.G., Henrisken L., and Overby V. J. Pharm. Biomed. Anal. 34 (2004) 265-276
13. Baertschi S.W. Trends Anal. Chem. 25 (2006) 758-767
14. Dorfman L. Chem. Rev. 53 (1953) 47-144 (relevant data on page 96)
15. Görög S., and Herényi B. J. Chromatogr. 400 (1987) 177-186
16. Cribb A.E., Knight M.J., Dryer D., Guernsey J., Hender K., Tesch M., and Saleh T.M. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 551-558
17. Xu X., Roman J.M., Veenstra T.D., Van Anda J., Ziegler R.G., and Issaq H.J. Anal. Chem. 78 (2006) 1553-1558
18. Thibaudeau J., Lepine J., Tojcic J., Duguay Y., Pelletier G., Plante M., Brisson J., Tetu B., Jacob S., Perusse L., Belanger A., and Guillemette C. Cancer Res. 66 (2006) 125-133
19. Xu X., Veenstra T.D., Fox S.D., Roman J.M., Issaq H.J., Falk R., Saavedra J.E., Keefer L.K., and Ziegler R.G. Anal. Chem. 77 (2005) 6646-6654
20. Modugno F., Kip K.E., Cochrane B., Kuller L., Klug T.L., Rohan T.E., Chlebowski R.T., Lasser N., and Stefanick M.L. Int. J. Cancer 118 (2006) 1292-1301
21. Rizzati V., Rathahao E., Gamet-Payrastre L., Delous G., Jouanin I., Gueraud F., and Paris A. Steroids 70 (2005) 161-172
22. Jacobsohn G.M., and Jacobsohn M.K. Arch. Biochem. Biophys. 232 (1984) 189-196